Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study-Reference-Cited by-同舟云学术

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study

Published:2017-02-13 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Casadei Gardini Andrea,Foca Flavia,Scartozzi Mario,Silvestris Nicola,Tamburini Emiliano,Faloppi Luca,Brunetti Oronzo,Rudnas Britt,Pisconti Salvatore,Valgiusti Martina,Marisi Giorgia,Foschi Francesco Giuseppe,Ercolani Giorgio,Tassinari Davide,Cascinu Stefano,Frassineti Giovanni Luca

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep42499.pdf

Reference28 articles.

1. Faloppi, L. et al. Evolving strategies for the treatment of hepatocellular carcinoma: From clinical-guided to molecularly-tailored therapeutic options. Cancer Treat Rev. 37, 169–177 (2011)

2. Llovet, J. M. et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 359, 378–390 (2008).

3. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guide-lines: management of hepatocellular carcinoma. Journal of Hepatology. 56, 908–43 (2012).

4. Shao, Y. Y. et al. Prognosis of patients with advanced hepatocel-lular carcinoma who failed first-line systemic therapy. Journal of Hepatology. 60, 313–8 (2014).

5. Reig, M. et al. Postprogression survival of patients withadvanced hepatocellular carcinoma: rationale for second-line trial design. Hepatology. 58, 2023–31 (2013).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care;Digestive and Liver Disease;2024-09

2. Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis;Journal of Gastrointestinal Cancer;2024-08-20

3. Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis;2024-06-09

4. Effectiveness and safety of anlotinib with or without S-1 in the treatment of patients with advanced hepatocellular carcinoma in a Chinese population: a prospective, phase 2 study;Radiology and Oncology;2023-07-26

5. Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients’ T cell ferroptosis;World Journal of Gastroenterology;2023-05-28